News
PRESS RELEASE : The smart choice in early-stage clinical research
CATALIS Québec launches a promotional campaign to demonstrate Quebec’s expertise in the conduct of early-phase clinical trials and to encourage new partnerships between the biopharmaceutical industry and university research centres.
Discover the hematology/oncology clinical research team at the Hôpital de l’Enfant-Jésus in Quebec City
Clinical trials, cell therapies and partnerships with different specialities: the hematology/oncology research team at the Hôpital de l’Enfant-Jésus (HEJ) in Quebec City is involved in all areas where research can make a difference for its patients.
The CHUM Research Centre’s Unit for Innovative Therapies Officially Opens
On August 29th, the management team at the CHUM Research Centre officially opened its Unit for Innovative Therapies (UIT), a competitive infrastructure for early-stage clinical research in Canada.
The challenges of patient clinical trial access
According to patient and caregiver associations, patients and the public at large should be better informed about clinical trials. Danika Laberge, general manager of CATALIS Québec, brought this subject up for discussion during the annual Innovative Medicines Canada conference on June 18th.
Pharmaceutical Industry Invests in the Development of Early Clinical Research in Quebec
CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.
CATALIS and its partners mark International Clinical Trials Day
To mark International Clinical Trials Day, on May 20, 2019, we will recognize the commitment of all research professionals who believe in the importance of clinical trials in generating innovative treatments for Quebec’s patients and citizens.
CATALIS and the McPeak-Sirois Group collaborate to promote the growth of clinical research in Quebec
The two organizations are joining forces to maximize the human and economic benefits of clinical trials province-wide.
Pooling Quebec’s clinical research resources to provide better patient care
How to propel Quebec to global leadership in early clinical research? Dr. Marc Rivière, the new chair of the board of directors of CATALIS Quebec, shares his vision.
A new tool for monitoring clinical research performance in Quebec
CATALIS has announced the implementation of a new automated performance report that will allow public institutions in the health and social service network to more easily access their clinical research performance data.
Novartis and Roche join the CATALIS Initiative
Novartis and Roche Join the CATALIS Initiative Industry partnership will help establish Quebec as a global leader in early stage clinical research MONTREAL, February 6, 2019— The CATALIS initiative is proud to announce that pharmaceutical companies Novartis and Roche have joined its partner network. A mere two years after its creation, CATALIS Québec has succeeded in mobilizing Quebec’s key players